171 related articles for article (PubMed ID: 817662)
41. Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests.
Sanders CC; Iaconis JP; Bodey GP; Samonis G
Antimicrob Agents Chemother; 1988 Sep; 32(9):1365-9. PubMed ID: 3143303
[TBL] [Abstract][Full Text] [Related]
42. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms.
Traub WH; Raymond EA
Appl Microbiol; 1971 Nov; 22(5):862-4. PubMed ID: 5210841
[TBL] [Abstract][Full Text] [Related]
43. Inter- and intralaboratory variability in antibiotic susceptibility tests with Pseudomonas aeruginosa and Enterobacteriaceae.
Barry AL; Schoenknecht FD; Norton R; O'Brien TF; Matsen JM; Thornsberry C; Thrupp LD; Markley E; Gavan TL
J Infect Dis; 1976 Oct; 134(4):328-35. PubMed ID: 185302
[TBL] [Abstract][Full Text] [Related]
44. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams].
Thabaut A; Meyran M
Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939
[TBL] [Abstract][Full Text] [Related]
45. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics.
Greenwood D; Eley A
J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389
[TBL] [Abstract][Full Text] [Related]
46. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
47. Comparative in vitro activity of LY 127935 (6059-S), seven cephalosporins, three aminoglycosides, carbenicillin, and ticarcillin.
Watanakunakorn C; Glotzbecker C
J Antibiot (Tokyo); 1979 Oct; 32(10):1019-24. PubMed ID: 528361
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of ampicillin-resistant Haemophilus influenzae to seven penicillins.
Thornsberry C; Baker CN; Kirven LA; Swenson JM
Antimicrob Agents Chemother; 1976 Jan; 9(1):70-3. PubMed ID: 1083202
[TBL] [Abstract][Full Text] [Related]
49. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
Høiby N; Bremmelgaard A; Schouenborg P
Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
[TBL] [Abstract][Full Text] [Related]
50. Activity of carbenicillin and ticarcillin against Pseudomonas aeruginosa compared by paired in vitro tests.
Mai K; Bülow B
Infection; 1974; 2(1):12-4. PubMed ID: 4208532
[No Abstract] [Full Text] [Related]
51. In vitro susceptibility of piperacillin v timentin and ticarcillin.
Bremner DA
N Z Med J; 1987 May; 100(823):299-300. PubMed ID: 3138579
[No Abstract] [Full Text] [Related]
52. The in vitro activity of beta-lactam antibiotics against gentamicin and/or carbenicillin-resistant Pseudomonas aeruginosa strains.
Aisa ML; Omenaca M; Bergua C; Garcia-Moya JB
Infection; 1982; 10 Suppl 3():S244-8. PubMed ID: 6818157
[TBL] [Abstract][Full Text] [Related]
53. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa.
Heym B; Lacroix O; Péan Y; Gertner J; Nicolas MH; Jarlier V
J Antimicrob Chemother; 1994 Apr; 33(4):729-35. PubMed ID: 8056691
[TBL] [Abstract][Full Text] [Related]
54. Comparison of minimum inhibitory concentration values determined by three antimicrobic dilution methods for Pseudomonas aeruginosa.
Woolfrey BF; Fox JM; Quall CO
Am J Clin Pathol; 1981 Jan; 75(1):39-44. PubMed ID: 6779623
[TBL] [Abstract][Full Text] [Related]
55. Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.
Paisley JW; Washington JA
Antimicrob Agents Chemother; 1978 Aug; 14(2):224-7. PubMed ID: 308792
[TBL] [Abstract][Full Text] [Related]
56. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime.
Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K
J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725
[No Abstract] [Full Text] [Related]
57. Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa.
Watanakunakorn C; Bannister T
Antimicrob Agents Chemother; 1974 Oct; 6(4):471-3. PubMed ID: 4157347
[TBL] [Abstract][Full Text] [Related]
58. Interpretive criteria for temocillin disk diffusion susceptibility testing.
Fuchs PC; Barry AL; Thornsberry C; Jones RN
Eur J Clin Microbiol; 1985 Feb; 4(1):30-3. PubMed ID: 3872793
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
Coppens L; Klastersky J
Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
[TBL] [Abstract][Full Text] [Related]
60. Pirbenicillin, a new semisynthetic penicillin with broad-spectrum activity.
Bodey GP; Rodriguez V; Weaver S
Antimicrob Agents Chemother; 1976 Apr; 9(4):668-74. PubMed ID: 817665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
